Pharmaceutical stocks are now on track to hit their milestone $50bn milestone within three years, according to a report from financial analysts at AlixPartners.AlixPartner, a global financial information provider, said the milestone would be achieved within three to four years if companies continue to invest in research and development (R&D) of new drugs.“These new companies […]

Continue Reading...